-
Je něco špatně v tomto záznamu ?
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
S. Mangiola, P. McCoy, M. Modrak, F. Souza-Fonseca-Guimaraes, D. Blashki, R. Stuchbery, SP. Keam, M. Kerger, K. Chow, C. Nasa, M. Le Page, N. Lister, S. Monard, J. Peters, P. Dundee, SG. Williams, AJ. Costello, PJ. Neeson, B. Pal, ND. Huntington,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
1054618
National Health and Medical Research Council
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- anotace sekvence MeSH
- imunofenotypizace MeSH
- imunohistochemie MeSH
- Kaplanův-Meierův odhad MeSH
- lidé MeSH
- monocyty metabolismus patologie MeSH
- nádorové mikroprostředí genetika MeSH
- nádory prostaty diagnóza genetika metabolismus mortalita MeSH
- prognóza MeSH
- progrese nemoci MeSH
- stanovení celkové genové exprese * metody MeSH
- transkriptom * MeSH
- výpočetní biologie metody MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Prostate cancer is caused by genomic aberrations in normal epithelial cells, however clinical translation of findings from analyses of cancer cells alone has been very limited. A deeper understanding of the tumour microenvironment is needed to identify the key drivers of disease progression and reveal novel therapeutic opportunities. RESULTS: In this study, the experimental enrichment of selected cell-types, the development of a Bayesian inference model for continuous differential transcript abundance, and multiplex immunohistochemistry permitted us to define the transcriptional landscape of the prostate cancer microenvironment along the disease progression axis. An important role of monocytes and macrophages in prostate cancer progression and disease recurrence was uncovered, supported by both transcriptional landscape findings and by differential tissue composition analyses. These findings were corroborated and validated by spatial analyses at the single-cell level using multiplex immunohistochemistry. CONCLUSIONS: This study advances our knowledge concerning the role of monocyte-derived recruitment in primary prostate cancer, and supports their key role in disease progression, patient survival and prostate microenvironment immune modulation.
Cancer Program Biomedicine Discovery Institute Monash University Clayton Victoria Australia
Department of Anatomy and Developmental Biology Monash University Clayton Victoria Australia
Department of Medical Biology University of Melbourne Melbourne Victoria Australia
Department of Surgery The University of Melbourne Parkville Victoria Australia
Department of Urology Frankston Hospital Frankston Victoria Australia
Department of Urology Royal Melbourne Hospital Parkville Victoria Australia
Epworth Center of Cancer Research Clayton Victoria Australia
Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic
Peter MacCallum Cancer Centre Melbourne VIC 3000 Australia
School of Mathematics and Statistics University of Melbourne Melbourne VIC 3010 Australia
Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Victoria Australia
The Olivia Newton John Cancer Research Institute Heidelberg Melbourne Australia
The Peter Doherty Institute for Infection and Immunity Parkville Victoria Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004064
- 003
- CZ-PrNML
- 005
- 20240206092824.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12885-021-08529-6 $2 doi
- 035 __
- $a (PubMed)34294073
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Mangiola, Stefano $u Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia $u Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
- 245 10
- $a Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression / $c S. Mangiola, P. McCoy, M. Modrak, F. Souza-Fonseca-Guimaraes, D. Blashki, R. Stuchbery, SP. Keam, M. Kerger, K. Chow, C. Nasa, M. Le Page, N. Lister, S. Monard, J. Peters, P. Dundee, SG. Williams, AJ. Costello, PJ. Neeson, B. Pal, ND. Huntington, NM. Corcoran, AT. Papenfuss, CM. Hovens
- 520 9_
- $a BACKGROUND: Prostate cancer is caused by genomic aberrations in normal epithelial cells, however clinical translation of findings from analyses of cancer cells alone has been very limited. A deeper understanding of the tumour microenvironment is needed to identify the key drivers of disease progression and reveal novel therapeutic opportunities. RESULTS: In this study, the experimental enrichment of selected cell-types, the development of a Bayesian inference model for continuous differential transcript abundance, and multiplex immunohistochemistry permitted us to define the transcriptional landscape of the prostate cancer microenvironment along the disease progression axis. An important role of monocytes and macrophages in prostate cancer progression and disease recurrence was uncovered, supported by both transcriptional landscape findings and by differential tissue composition analyses. These findings were corroborated and validated by spatial analyses at the single-cell level using multiplex immunohistochemistry. CONCLUSIONS: This study advances our knowledge concerning the role of monocyte-derived recruitment in primary prostate cancer, and supports their key role in disease progression, patient survival and prostate microenvironment immune modulation.
- 650 _2
- $a výpočetní biologie $x metody $7 D019295
- 650 _2
- $a progrese nemoci $7 D018450
- 650 12
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a imunofenotypizace $7 D016130
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a anotace sekvence $7 D058977
- 650 _2
- $a monocyty $x metabolismus $x patologie $7 D009000
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádory prostaty $x diagnóza $x genetika $x metabolismus $x mortalita $7 D011471
- 650 12
- $a transkriptom $7 D059467
- 650 _2
- $a nádorové mikroprostředí $x genetika $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a McCoy, Patrick $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 700 1_
- $a Modrák, Martin $u Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic $7 xx0313530
- 700 1_
- $a Souza-Fonseca-Guimaraes, Fernando $u University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia
- 700 1_
- $a Blashki, Daniel $u The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia
- 700 1_
- $a Stuchbery, Ryan $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 700 1_
- $a Keam, Simon P $u Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia $u Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia
- 700 1_
- $a Kerger, Michael $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 700 1_
- $a Chow, Ken $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 700 1_
- $a Nasa, Chayanica $u Flow Cytometry Facility, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
- 700 1_
- $a Le Page, Melanie $u Flow Cytometry Facility, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
- 700 1_
- $a Lister, Natalie $u Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia $u Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
- 700 1_
- $a Monard, Simon $u Flow Cytometry Facility, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
- 700 1_
- $a Peters, Justin $u Epworth Center of Cancer Research, Clayton, Victoria, Australia
- 700 1_
- $a Dundee, Phil $u Epworth Center of Cancer Research, Clayton, Victoria, Australia
- 700 1_
- $a Williams, Scott G $u Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia $u Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia
- 700 1_
- $a Costello, Anthony J $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 700 1_
- $a Neeson, Paul J $u Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia $u Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia
- 700 1_
- $a Pal, Bhupinder $u The Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Australia
- 700 1_
- $a Huntington, Nicholas D $u Cancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia $u Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia
- 700 1_
- $a Corcoran, Niall M $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia $u Department of Urology, Frankston Hospital, Frankston, Victoria, Australia
- 700 1_
- $a Papenfuss, Anthony T $u Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. papenfuss@wehi.edu.au $u Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. papenfuss@wehi.edu.au $u Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. papenfuss@wehi.edu.au $u Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. papenfuss@wehi.edu.au $u School of Mathematics and Statistics, University of Melbourne, Melbourne, VIC, 3010, Australia. papenfuss@wehi.edu.au
- 700 1_
- $a Hovens, Christopher M $u Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia $u Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
- 773 0_
- $w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 21, č. 1 (2021), s. 846
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34294073 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20240206092821 $b ABA008
- 999 __
- $a ok $b bmc $g 1751507 $s 1155213
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 21 $c 1 $d 846 $e 20210722 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
- GRA __
- $a 1054618 $p National Health and Medical Research Council
- LZP __
- $a Pubmed-20220113